Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy J Müller, G Wallukat, YG Weng, M Dandel, S Spiegelsberger, S Semrau, ... Circulation 96 (2), 542-549, 1997 | 444 | 1997 |
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphological and Clinicopathological Spectrum of a Recently Described Entity A Agaimy, A Hartmann, CR Antonescu, SI Chiosea, SK El-Mofty, ... The American journal of surgical pathology 41 (4), 458, 2017 | 215 | 2017 |
Safety and efficacy of stereotactic body radiotherapy for stage I non–small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis M Guckenberger, M Allgäuer, S Appold, K Dieckmann, I Ernst, ... Journal of Thoracic Oncology 8 (8), 1050-1058, 2013 | 210 | 2013 |
SMARCB1 (INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms A Agaimy, M Koch, M Lell, S Semrau, W Dudek, DL Wachter, A Knöll, ... The American journal of surgical pathology 38 (9), 1274, 2014 | 154 | 2014 |
Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients M Hecht, L Zimmer, C Loquai, C Weishaupt, R Gutzmer, B Schuster, ... Annals of Oncology 26 (6), 1238-1244, 2015 | 133 | 2015 |
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small … M Guckenberger, RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, ... Radiotherapy and Oncology 109 (1), 13-20, 2013 | 129 | 2013 |
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy M Guckenberger, RJ Klement, M Allgäuer, N Andratschke, O Blanck, ... Radiotherapy and Oncology 118 (3), 485-491, 2016 | 123 | 2016 |
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, U Ganswindt, ... International Journal of Radiation Oncology* Biology* Physics 88 (3), 732-738, 2014 | 69 | 2014 |
Stereotactic body radiotherapy for centrally located stage I NSCLC DH Schanne, U Nestle, M Allgäuer, N Andratschke, S Appold, ... Strahlentherapie und Onkologie 191 (2), 125-132, 2015 | 67 | 2015 |
Magnetic resonance imaging for brain stereotactic radiotherapy F Putz, V Mengling, R Perrin, S Masitho, T Weissmann, J Rösch, ... Strahlentherapie und Onkologie, 1-13, 2020 | 62 | 2020 |
Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio therapy for Organ … S Semrau, F Waldfahrer, M Lell, R Linke, G Klautke, T Kuwert, M Uder, ... Strahlentherapie und Onkologie 187 (1), 15-22, 2011 | 55 | 2011 |
6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer S Semrau, A Bier, U Thierbach, C Virchow, P Ketterer, G Klautke, ... Strahlentherapie und Onkologie 183 (1), 30-35, 2007 | 54 | 2007 |
Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of … S Semrau, A Bier, U Thierbach, C Virchow, P Ketterer, R Fietkau Strahlentherapie und Onkologie 179 (12), 823-831, 2003 | 52 | 2003 |
High‐grade histology as predictor of early distant metastases and decreased disease‐free survival in salivary gland cancer irrespective of tumor subtype M Haderlein, C Scherl, S Semrau, S Lettmaier, W Uter, FW Neukam, H Iro, ... Head & neck 38 (S1), E2041-E2048, 2016 | 49 | 2016 |
Primary glioblastoma multiforme tumors and recurrence C Muth, Y Rubner, S Semrau, PF Rühle, B Frey, A Strnad, R Buslei, ... Strahlentherapie und Onkologie 192 (3), 146-155, 2016 | 48 | 2016 |
Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy R Merten, M Hecht, M Haderlein, L Distel, R Fietkau, L Heinzerling, ... Strahlentherapie und Onkologie 190 (12), 1169-1172, 2014 | 47 | 2014 |
Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments RJ Klement, JJ Sonke, M Allgäuer, N Andratschke, S Appold, J Belderbos, ... International Journal of Radiation Oncology* Biology* Physics, 2020 | 45 | 2020 |
Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy S Semrau, G Klautke, JC Virchow, G Kundt, R Fietkau Respiratory medicine 102 (2), 210-218, 2008 | 45 | 2008 |
Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx S Semrau, D Schmidt, M Lell, F Waldfahrer, S Lettmaier, T Kuwert, H Iro, ... Oral oncology 49 (5), 454-460, 2013 | 41 | 2013 |
Single‐cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis? S Semrau, M Haderlein, D Schmidt, M Lell, W Wolf, F Waldfahrer, M Uder, ... Cancer 121 (8), 1214-1222, 2015 | 40 | 2015 |